XML 65 R43.htm IDEA: XBRL DOCUMENT v3.21.2
Summary of Significant Accounting Policies - Schedule of Intangible Assets (Detail) - USD ($)
3 Months Ended 12 Months Ended
Sep. 25, 2021
Dec. 26, 2020
Dec. 28, 2019
Mar. 30, 2019
Sep. 28, 2019
Jun. 26, 2021
Mar. 27, 2021
Sep. 26, 2020
Finite-Lived Intangible Assets [Line Items]                
Gross Carrying Value $ 5,582,100,000             $ 4,931,100,000
Accumulated Amortization 3,922,900,000             3,623,600,000
Impairment charge 1,800,000 $ 30,200,000 $ 30,200,000 $ 685,400,000        
Developed technology                
Finite-Lived Intangible Assets [Line Items]                
Gross Carrying Value 4,597,700,000             4,054,000,000
Accumulated Amortization 3,184,200,000             2,907,200,000
In-process research and development                
Finite-Lived Intangible Assets [Line Items]                
Gross Carrying Value 71,600,000             0
Accumulated Amortization 0             0
Customer relationships                
Finite-Lived Intangible Assets [Line Items]                
Gross Carrying Value 591,700,000             549,100,000
Accumulated Amortization 510,100,000             477,800,000
Trade names                
Finite-Lived Intangible Assets [Line Items]                
Gross Carrying Value 268,100,000             245,500,000
Accumulated Amortization 191,800,000             181,200,000
Non-competition agreements                
Finite-Lived Intangible Assets [Line Items]                
Gross Carrying Value 1,500,000             1,500,000
Accumulated Amortization 1,500,000             1,300,000
Business licenses                
Finite-Lived Intangible Assets [Line Items]                
Gross Carrying Value 2,500,000             2,400,000
Accumulated Amortization 2,500,000             2,300,000
Acquired intangible assets [Member]                
Finite-Lived Intangible Assets [Line Items]                
Gross Carrying Value 5,533,100,000             4,852,500,000
Accumulated Amortization 3,890,100,000             3,569,800,000
Internal-use software [Member]                
Finite-Lived Intangible Assets [Line Items]                
Gross Carrying Value 23,500,000             51,800,000
Accumulated Amortization 17,200,000             43,200,000
Capitalized software [Member]                
Finite-Lived Intangible Assets [Line Items]                
Gross Carrying Value 25,500,000             26,800,000
Accumulated Amortization $ 15,600,000             10,600,000
Medical Aesthetics                
Finite-Lived Intangible Assets [Line Items]                
Impairment charge     $ 30,200,000          
Medical Aesthetics | Developed Technology                
Finite-Lived Intangible Assets [Line Items]                
Impairment charge         $ 576,900,000      
Medical Aesthetics | Customer Relationships                
Finite-Lived Intangible Assets [Line Items]                
Impairment charge         22,400,000      
Medical Aesthetics | Trade names                
Finite-Lived Intangible Assets [Line Items]                
Impairment charge         48,600,000      
Medical Aesthetics | Property, Plant and Equipment [Member]                
Finite-Lived Intangible Assets [Line Items]                
Impairment charge         $ 9,800,000      
Mobidiag Oy | In-process research and development                
Finite-Lived Intangible Assets [Line Items]                
Identifiable intangible assets:           $ 74,000,000    
Mobidiag Oy | Trade names                
Finite-Lived Intangible Assets [Line Items]                
Identifiable intangible assets:           20,000,000    
Mobidiag Oy | Customer Relationships                
Finite-Lived Intangible Assets [Line Items]                
Identifiable intangible assets:           20,900,000    
Mobidiag Oy | Developed Technology                
Finite-Lived Intangible Assets [Line Items]                
Identifiable intangible assets:           $ 285,000,000    
Biotheranostics | Trade names                
Finite-Lived Intangible Assets [Line Items]                
Identifiable intangible assets:             $ 2,100,000  
Biotheranostics | Developed Technology                
Finite-Lived Intangible Assets [Line Items]                
Identifiable intangible assets:             160,300,000  
Diagenode | Customer Relationships                
Finite-Lived Intangible Assets [Line Items]                
Identifiable intangible assets:             9,200,000  
Diagenode | Developed Technology                
Finite-Lived Intangible Assets [Line Items]                
Identifiable intangible assets:             69,800,000  
Somatex | Customer relationships                
Finite-Lived Intangible Assets [Line Items]                
Identifiable intangible assets:             1,200,000  
Somatex | Trade names                
Finite-Lived Intangible Assets [Line Items]                
Identifiable intangible assets:             900,000  
Somatex | Developed Technology                
Finite-Lived Intangible Assets [Line Items]                
Identifiable intangible assets:             $ 38,000,000  
Acessa Health | Trade names                
Finite-Lived Intangible Assets [Line Items]                
Identifiable intangible assets:               1,200,000
Acessa Health | Developed Technology                
Finite-Lived Intangible Assets [Line Items]                
Identifiable intangible assets:               $ 127,000,000